Table 3.
Multiple linear regression analysis of anti-SARS-CoV-2 RBD IgG antibody levels above positivity cutoff in SARS-CoV-2 sero-negative individuals (2013 and 2020) and SARS-CoV-2 sero-positive individuals, with adjustment for age, sex, and anti-HCoV IgG signals.
| Variable | 2013 (N = 329) | 2020 (N = 83) | SARS-CoV-2 Sero-Positives (N = 27) | |||
|---|---|---|---|---|---|---|
| Coefficient | P-value | Coefficient | P-value | Coefficient | P-value | |
| (Intercept) | 4.009 | – | 3.685 | – | -7.787 | – |
| Age | 0.005 | <0.001 | 0.001 | 0.461 | -0.029 | 0.127 |
| Sex (Male) | 0.035 | 0.372 | 0.021 | 0.818 | -0.606 | 0.380 |
| log(HCoV-229E Spike) | 0.116 | <0.001 | 0.0215 | <0.001 | 0.734 | 0.175 |
| log(HCoV-HKU1 Spike) | 0.087 | <0.001 | 0.065 | 0.183 | -0.251 | 0.648 |
| log(HCoV-NL63 Spike) | 0.022 | 0.379 | 0.047 | 0.449 | -0.549 | 0.252 |
| log(HCoV-OC43 Spike) | 0.031 | 0.243 | -0.036 | 0.629 | 1.604 | 0.023 |
| Adjusted R-squared | 0.233 | 0.195 | 0.335 | |||